This site is intended for healthcare professionals only
LoginRegister
Boehringer, Click Therapeutics investigational prescription digital therapeutic meets primary endpoint in study for schizophreniaBoehringer Ingelheim gets USFDA priority review for Zongertinib for HER2 (ERBB2)-mutant advanced...
Unichem Labs Roha facility gets 3 USFDA observationsAurobindo Pharma USA New Jersey warehouse gets USFDA OAI status
Imbruvica gets positive EMA Committee opinion for untreated mantle cell lymphoma eligible for Stem Cell Transplant: Janssen-Cilag InternationalJnJ to resume US VARIPULSE cases
CDSCO Committee Calls for Stronger Action Against Fake Medicines, Stricter Quality ChecksCDSCO Committee Calls for Stronger Action Against Fake Medicines, Stricter Quality Checks
Indian shares end flat as financials offset declines in pharma, ITIndian shares end flat as financials offset declines in pharma, IT
Cipla Bommasandra facility gets VAI classification from USFDACipla completes investment of ZAR 900 million in South Africa subsidiary
Gland Pharma gets USFDA okay for Norepinephrine Bitartrate in 5% Dextrose Injection BagsInnocan Pharma gets patent in India for Liposomal CBD Injection
Trodelvy plus Keytruda effective for aggressive breast cancer type: Gilead SciencesGilead new drug applications for twice-yearly Lenacapavir for HIV Prevention accepted by USFDA under...
USFDA concludes inspection at Zydus Lifesciences SEZ II, Ahmedabad plantUSFDA issues 6 observations for Piramal Pharma Turbhe facility
Aurobindo Pharma arm gets European Commission authorization to market Dyrupeg in EUAurobindo Pharma arm Eugia Steriles gets 5 UFSDA observations
Merck to begin Phase 3 trials for investigational once monthly HIV prevention pillMerck Welireg receives European Commission nod for two indications
Revise MRP of drugs given custom duty relaxations in budget: NPPA directs Pharma Firms, MarketersRevise MRP of drugs given custom duty relaxations in budget: NPPA directs Pharma Firms, Marketers
X